Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

CNTX Context Therapeutics Inc

0.00 (0.00%)
Pre Market
Last Updated: 07:41:10
Delayed by 15 minutes


Draw Mode:

Volume 37
Bid Price 1.35
Ask Price 1.53
News -
Day High


52 Week Range


Day Low
Company Name Stock Ticker Symbol Market Type
Context Therapeutics Inc CNTX NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.00 0.00% 1.41 07:41:10
Open Price Low Price High Price Close Price Prev Close
Trades Volume Avg Volume 52 Week Range
2 37 - 0.47 - 1.69
Last Trade Time Type Quantity Stock Price Currency
07:01:28 23 $ 1.36 USD

Context Therapeutics Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
22.51M 15.97M - 0 -23.96M -1.50 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Context Therapeutics News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No CNTX Message Board. Create One! See More Posts on CNTX Message Board See More Message Board Posts

Historical CNTX Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week1.481.581.3651.4653,253-0.07-4.73%
1 Month1.091.601.081.3698,6520.3229.36%
3 Months0.92021.600.92021.2658,4180.489853.23%
6 Months1.241.600.771.1850,5770.1713.71%
1 Year0.661.690.471.0974,6790.75113.64%
3 Years4.4410.870.473.94832,078-3.03-68.24%
5 Years4.4410.870.473.94832,078-3.03-68.24%

Context Therapeutics Description

Context Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to improving the lives of women living with cancer. The development team is advancing a pipeline of innovative therapies with a primary focus on treating female, hormone-dependent cancer, including breast, ovarian, and endometrial cancer.

Your Recent History

Delayed Upgrade Clock